1. Increased energy demand from anabolic-catabolic processes drives β-lactam antibiotic lethality.
- Author
-
Lobritz MA, Andrews IW, Braff D, Porter CBM, Gutierrez A, Furuta Y, Cortes LBG, Ferrante T, Bening SC, Wong F, Gruber C, Bakerlee CW, Lambert G, Walker GC, Dwyer DJ, and Collins JJ
- Subjects
- Amdinocillin chemistry, Anti-Bacterial Agents chemistry, Escherichia coli metabolism, Escherichia coli Proteins metabolism, Homeostasis drug effects, Microbial Sensitivity Tests, Penicillin-Binding Proteins metabolism, Amdinocillin pharmacology, Anti-Bacterial Agents pharmacology, Escherichia coli drug effects, Escherichia coli Proteins antagonists & inhibitors, Penicillin-Binding Proteins antagonists & inhibitors
- Abstract
β-Lactam antibiotics disrupt the assembly of peptidoglycan (PG) within the bacterial cell wall by inhibiting the enzymatic activity of penicillin-binding proteins (PBPs). It was recently shown that β-lactam treatment initializes a futile cycle of PG synthesis and degradation, highlighting major gaps in our understanding of the lethal effects of PBP inhibition by β-lactam antibiotics. Here, we assess the downstream metabolic consequences of treatment of Escherichia coli with the β-lactam mecillinam and show that lethality from PBP2 inhibition is a specific consequence of toxic metabolic shifts induced by energy demand from multiple catabolic and anabolic processes, including accelerated protein synthesis downstream of PG futile cycling. Resource allocation into these processes is coincident with alterations in ATP synthesis and utilization, as well as a broadly dysregulated cellular redox environment. These results indicate that the disruption of normal anabolic-catabolic homeostasis by PBP inhibition is an essential factor for β-lactam antibiotic lethality., Competing Interests: Declaration of interests M.A.L. is a full-time employee and shareholder of F. Hoffmann-La Roche, Ltd. J.J.C. is a scientific co-founder and scientific advisory board chair of Enbiotix, an antibiotics discovery company., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF